TORONTO, Ontario and BROSSARD, Québec, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global vertically integrated Bitcoin mining data center company, will report its second quarter 2024 financial results on Thursday, August 8th, before the market opens. Management will host a conference call on the same day at 8:00 am EST. All Q2 2024 materials will be available before the call and can be accessed on the 'Financial Results' section of the Bitfarms investor site. Participants may join ...

~ Announced RMAT designation for AMT-130 in Huntington's disease and positive interim Phase I/II data demonstrating the slowing of disease progression and reductions in a key biomarker of neurodegeneration; Meeting with FDA expected in the second half of 2024 to discuss potential for expedited clinical development ~ ~ Initiated patient screening for three additional Phase I/II studies in mesial temporal lobe epilepsy, SOD1 ALS, and Fabry disease ~ ~ Today, announced an organizational restructuring intended ...

文章核心观点 - 公司在第二季度取得了良好的业绩表现 [2][3] - 公司的两款主要产品SYFOVRE和EMPAVELI在美国市场持续增长 [4][5] - 公司正在积极推进临床试验进度,包括C3G/IC-MPGN适应症的III期试验和HSCT-TMA适应症的II期试验 [6][7] - 公司财务状况良好,现金储备充足,预计可以支持公司运营直至实现正现金流 [14][15] 财务摘要 - 第二季度总收入为1.997亿美元,其中SYFOVRE和EMPAVELI在美国的净产品销售额分别为1.546亿美元和2,450万美元 [9] - 销售成本为2,310万美元,较上年同期增加,主要由于商业销量和患者援助计划的增加 [10] - 研发费用为7,790万美元,较上年同期有所下降 [11] - 销售及管理费用为12,810万美元,较上年同期有所增加 [12] - 公司第二季度净亏损为3,770万美元,较上年同期大幅收窄 [13] - 截至6月30日,公司现金及现金等价物为3.601亿美元 [14] 业务进展 眼科业务 - SYFOVRE在地理性萎缩(GA)治疗领域保持市场领导地位,第二季度销售额达1.546亿美元 [4] - 累计已有超过33万人接受SYFOVRE治疗,两大国家药品福利管理公司已将其列为优先产品 [4] - 公司已就SYFOVRE在欧洲的上市申请重新提交审查,预计将在第四季度获得最终决定 [4] 血液病业务 - EMPAVELI在阵发性睡眠性血红蛋白尿症(PNH)治疗领域持续表现良好,第二季度销售额达2,450万美元 [5] - 患者依从性保持在97%的高水平 [5] 研发进展 - C3肾小球肾炎(C3G)和原发性免疫复合物肾小球肾炎(IC-MPGN)III期VALIANT试验预计将于8月份公布结果 [6] - HSCT-TMA适应症II期试验正在持续推进 [7] - APL-3007小干扰RNA沉默C3的I期试验预计2024年内公布结果 [7]

文章核心观点 - 霍华德·休斯公司(HHH)完成了将其海港娱乐部门分拆为独立上市公司Seaport Entertainment Group Inc.的交易[1][2][5] - 分拆后,HHH将成为一家专注于大型综合社区开发的纯地产公司,拥有101,000英亩的全国性地产组合,包括35,000英亩的土地储备[3][4] - HHH在拉斯维加斯的Summerlin、夏威夷的Ward Village、马里兰的Downtown Columbia、休斯顿大区的The Woodlands和Bridgeland以及凤凰城西区的Teravalis等社区取得了创纪录的业绩[3] 公司概况 - HHH是一家拥有全国性地产组合的大型综合社区开发商[3][7] - 公司的主要资产包括获奖的大型综合社区、运营性房地产和开发机会[7] - 公司的地产组合战略性地布局,能够满足并加速市场需求,形成了该行业最强大的房地产平台之一[7] - 公司致力于创新的场所营造,并持续致力于设计卓越和社区文化生活[7] 分拆交易 - 根据分拆条款,在2024年7月31日收市后,每持有9股HHH普通股的股东将获得1股Seaport Entertainment Group普通股[2] - Seaport Entertainment Group普通股将于当日在纽约证券交易所美国板块以"SEG"代码开始交易,而HHH普通股将继续在纽约证券交易所以"HHH"代码交易[5] - 富国银行担任HHH的财务顾问,拉森和沃金斯LLP担任法律顾问,摩根大通证券公司担任Seaport Entertainment Group的财务顾问,理查兹、莱顿和芬格公司担任法律顾问[6]

Combination Creates a Comprehensive Solutions Provider to Building Products OEMs Acquisition Enhances Scale, Global Reach and Product Offering HOUSTON, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE: NX) ("Quanex" or the "Company") today announced that it has closed on its acquisition of Tyman plc ("Tyman"), creating a comprehensive solutions provider in the building products industry. "We are excited to welcome the Tyman team. This transaction accelerates our growth and value ...

MILWAUKEE, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE:BRC) ("Brady") today announced that it has completed its acquisition of Gravotech Holding ("Gravotech"), a leader in specialized marking and engraving solutions, in a transaction valued at EUR 120 million (approximately USD 130 million). "We are pleased to welcome the Gravotech team to Brady," said Brady's President and Chief Executive Officer, Russell R. Shaller. "Gravotech offers specialty laser and mechanical engraving capabilities inte ...

CLEVELAND, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Christopher Simon as a new independent director to its Board of Directors. Mr. Simon will serve as a member of the Leadership Development and Compensation Committee of the Board of Directors. For approximately the past eight years, Mr. Simon has ser ...

DUBLIN, Aug. 1, 2024 /PRNewswire/ -- AerCap Holdings N.V. ("AerCap" or the "Company") (NYSE: AER) today announced the delivery of the first three of fifteen new Airbus A321neo aircraft on long-term lease to AirAsia Group* (AirAsia). The remaining 12 units are scheduled to deliver in 2024 and 2025. To mark the delivery of the new A321neo aircraft and the strengthening of their operational fleet to 200 aircraft, AirAsia hosted a special ceremony at their corporate headquarters, RedQ in Malaysia. The event was ...

YOKNEAM, Israel, Aug. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights: | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Newly published in the peer-reviewed journal Antibiotics, the 331-patient Phase 3 Crohn's disease study data shows the primary endpoint of clinical remission at week 26 was achieved, with high statistical significance, in 36.7% (61/166) of orally administered RHB-104 plus standard of care (SoC) patients, compared to 22.4% (37/165) of placebo plus SoC patients (p=0.0048); Safety profile similar to placebo. Study conducted across more than 100 sites The advanced stage clinical data demonstrating the potential ...